Clinical Trials Logo

Filter by:
NCT ID: NCT05764408 Completed - Fetal Anomaly Clinical Trials

Pannus Assistance Needed for Obstetric Ultrasound Studies

Start date: March 10, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to evaluate whether use of a pannus retractor adhesive improves fetal anatomic ultrasound examinations. The primary question it aims to answer is: • Does the use of a pannus retractor adhesive increase the rate of detailed anatomic survey completion, defined by satisfactory visualization of sixteen prespecified fetal anatomy views, for participants with a pannus and body mass index of at least 40 kg/m2?

NCT ID: NCT05764265 Completed - Clinical trials for Pulmonary Arterial Hypertension

Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

Start date: March 27, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to measure the long-term safety and efficacy profile of LTP001 in participants with pulmonary arterial hypertension (PAH). The study offers participants who had completed the CLTP001A12201 double-blind parent study in PAH an opportunity to receive LTP001 (whether they were on LTP001 or not). Unblinding of the treatment received in CLTP001A12201 is generally not needed, but can occur on request by the investigator.

NCT ID: NCT05764174 Completed - COVID-19 Clinical Trials

Digital Applications to Monitor Novel Coronavirus Disease and Response in Colombia - Syndromic and Vaccination Surveillance

DIAMOND-R
Start date: September 21, 2022
Phase: N/A
Study type: Interventional

Brief Summary: The main objective of this activity is to assess the effectiveness of different messaging strategies (factual, narrative, mixed and a control) to promote COVID-19 adult vaccination.

NCT ID: NCT05764005 Completed - Prostate Cancer Clinical Trials

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

Start date: November 9, 2022
Phase: N/A
Study type: Interventional

This is a pilot evaluation of a patient-centered intervention that enables providers to support men on active surveillance to maximize adherence. Conducted in urology practices, this pilot will measure key patient-reported, provider-reported, and implementation outcomes. Successful completion of this work will inform a subsequent multi-center effectiveness-implementation hybrid design trial and ultimately will improve low-risk cancer management by effectively engaging Primary Care Physicians (PCPs) in care delivery.

NCT ID: NCT05763628 Completed - Presbyopia Clinical Trials

Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses

Start date: December 10, 2022
Phase: N/A
Study type: Interventional

The objective of the study is to compare the lens performance of two daily disposable multifocal contact lenses.

NCT ID: NCT05763459 Completed - Healthy Clinical Trials

A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects

Start date: March 24, 2023
Phase: Phase 1
Study type: Interventional

This study follows an open-label, single arm design with two periods with rosuvastatin, digoxin and ABBV-CLS-7262

NCT ID: NCT05763264 Completed - Contraception Clinical Trials

TITLE SAGCS2 Protocol 2.3 + Amend 1

Start date: October 12, 2020
Phase: N/A
Study type: Interventional

The clinical study will compare two lubricated polyurethane male condoms of different thickness with a marketed lubricated control male condom made of natural rubber latex. This crossover study will randomize 300 heterosexual couples to the sequence in which they use five condoms of each of the three study condom types. The clinical failure (breakage and slippage) rates of the two polyurethane condoms will be compared to the clinical failure (breakage and slippage) rate of commercial natural rubber latex control condom using a statistical test of non-inferiority. The study will also compare the acceptability of the two polyurethane condom different thickness with that of the natural rubber latex control condom obtained from interviews and questionnaires with subject couples.

NCT ID: NCT05763160 Completed - Submental Fat Clinical Trials

An Open-label Study That Will Test a Second Treatment Session of RZL-012.

Start date: May 29, 2023
Phase: Phase 2
Study type: Interventional

This is a Phase 2, open-label study in which subjects seeking further improvement of their SMF will be treated with a second treatment session of RZL-012. The second treatment session will be offered to subjects previously treated with RZL-012 under protocols RZL-012-SMF-SWMTG-P2US-001 or RZL-012-SMFC-P2US-001. Subjects who fully completed either of the trials and whose C-CAT score is 2, 3 or 4 will be eligible to participate in the new trial. For each subject, the study will consist of a screening period, baseline period in which subjects will receive a second treatment session of RZL-012 and a follow-up period. RZL-012 will be administered during a single treatment session via multiple injections into the submental area under the chin. Subjects will thereafter be monitored for safety and efficacy for at least 84 days.

NCT ID: NCT05763082 Completed - Plaque Psoriasis Clinical Trials

Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis

Start date: February 7, 2023
Phase: Phase 3
Study type: Interventional

To compare the safety and efficacy of Padagis' product to an FDA approved product for the treatment of plaque psoriasis

NCT ID: NCT05762978 Completed - Asthma Clinical Trials

Evaluation of Negative Inspiratory Flow in Children With Acute Asthma

Start date: December 2015
Phase: N/A
Study type: Interventional

There are different inhalers used for the treatment of asthma and they work differently and require different technique for the optimal drug delivery to the lungs. One of the inhalers is the Dry Powder Inhaler (DPI). The minimal amount of Negative Inspiratory Flow (NIF) required to use this medication is 30ml/min. Studies have shown that children find it difficult to generate this NIF and studies have also shown that children generate lesser NIF during an Asthma exacerbation. The investigators will measure the NIF using an InCheck Dial on children with asthma during an exacerbation and when they are seen in clinic for a hospital follow up visit. This will be done on asthmatic children regardless of the inhaler that they use. The investigator hypothesize that children with asthma age 4-8 years cannot generate the required NIF during an Asthma exacerbation hence proving that a DPI cannot be prescribed to children at this age. This study will examine this hypothesis.